Gary Zamler to Lead Simbionix to Its Next Stage of Growth as Leading International Medical Simulation and Training Solutions Provider.

CLEVELAND & LOD, Israel -- Simbionix USA Corporation (Simbionix), a developer of medical simulators and hands-on curriculum for training medical professionals, today announced that Gary Zamler will join the company as Chief Executive Officer (CEO) on April 10th, 2006.

Gary brings a rich background of over 20 years of global distribution experience working within the medical technology industry. Most recently Gary was the Director of Sales for the rapidly growing Given Imaging Ltd (NASDAQ:GIVN), which pioneered the field of wireless Capsule Endoscopy. During his 3 1/2 years at Given, which saw revenues grow from $9M to $87M, Gary was involved in the distribution of Given Imaging products throughout the globe, in North and South America, Europe, and most recently focused on Asia where he has been involved in developing the company's distribution channel strategy in China and other emerging Asian markets.

Prior to joining Given, Gary held key management positions in several leading International Medical Diagnostic Imaging companies: Country Sales Manager for GE Medical Systems, Israel, CT Global Sales Manager, for Marconi Medical (former Picker International), VP of Commercial Operations for Elscint's largest subsidiary in the USA, and Managing Director and General Manager for Elscint's Diagnostic Imaging operations in Southern Africa.

"We are delighted with the energy and global sales expertise Gary brings to Simbionix," said Simbionix Chairman, Dr. Avshalom Horan. "With his extensive experience in high growth medical technology companies, I'm confident Gary will lead our existing management team to help Simbionix become a global leader in medical simulation and training solutions."

Gary added, "In my view, Simbionix possesses two critical elements for success--a world class team of dedicated professional people, and a very strong technology platform. I am extremely excited about the opportunity to join such an innovative company, especially when the Industry now understands the importance of medical simulation and requires solutions for physician training. Looking ahead, I see the potential for substantial growth with the introduction of Simbionix's 'Total Solution', which encompasses web-based didactic training with hands-on simulation training and immediate feedback to the medical professional. These tools will provide the medical community with a new and more effective way to learn complex minimally invasive procedures."

"Gary's proven team-building skills and global sales and marketing experience bring additional depth to our team. We are excited to have Gary join us to help drive the company to the next level as a leading international medical simulation and training solutions provider," commented Ran Bronstein, Founder, President and Chief Operating Officer.

Since its inception in 1997, Simbionix has raised about $11 million including investment from the institutional investors Early Stage Partners and Koor Corporate VC. The Company will seek to raise additional financing later in 2006 or during the first half of 2007, in order to fund the global roll out of its Total Solution simulation product offering.

Simbionix is a global leader in medical simulation technology. The company's mission is to provide state of the art, simulation-based medical education and training systems, and to set the standard for minimally invasive surgical training and performance. Since the successful introduction of the GI Mentor(TM) to the world market in 2000, Simbionix completed four other medical training simulators, which provide medical experts with hands-on training in a comprehensive array of Minimally Invasive Surgery procedures; the URO Mentor(TM) - a simulator for endourology procedures, the PERC Mentor(TM) for percutaneous access procedures, the LAP Mentor(TM) - a multi disciplinary simulator for laparoscopic skills and surgery procedures, and the recently launched and enthusiastically received ANGIO Mentor(TM) for interventional cardiologists, interventional radiologist and vascular surgeons that can use it to perform complete procedures, as well as acquiring basic skills. Additional company information can be found at http://www.simbionix.com/

Early Stage Partners LP http://www.esplp.com/team.html is the most active early stage venture capital fund based in Cleveland, Ohio. Early Stage Partners was formed to fill an unserved market need in financing the commercialization of world-class technologies. The company invests primarily in promising opportunities in the life sciences; enterprise software, supply chain management, polymers and advanced materials.

Koor Corporate Venture Capital, (NYSE:KOR, TASE) http://www.koor.com is the venture capital arm of Koor Industries - one of the Israel's largest investment-holding company ($1 billion). KVC invests in the areas of telecommunications technology, internet infrastructure, enterprise software and life sciences.

Shestra (Switzerland), one of the earliest investors in Simbionix. is a Geneva-based private equity banking group.